僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Nemolizumab （CIM331） is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 （IL-31） to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis （AD）